A-1 Ltd FY26 Financials and Strategic Expansion

Net Profit rose to Rs 5.99 crore, while revenue reached Rs 342.91 crore.

Reader Takeaway: Strong profit growth and corporate actions are offset by risks from raw material volatility and intense competition.

What just happened

A-1 Ltd reported a healthy increase in profitability for FY26, with consolidated net profit climbing to Rs 5.99 crore from Rs 3.65 crore in the prior year. Revenue from operations also saw growth, rising to Rs 342.91 crore from Rs 331.49 crore. Alongside these results, the company declared a final dividend of Rs 0.05 per share, payable on October 24, 2026, for shareholders of record as of September 18, 2026.

Corporate Actions

The company confirmed the execution of a 3:1 bonus issue and a 10:1 stock split, which adjusted the share face value from Rs 10 to Rs 1. These actions were previously approved in December 2025.

Business Pivot

A-1 Ltd is moving beyond its core industrial acid and chemicals trading business. The company has officially amended its Memorandum of Association to include the trading of sports equipment and the contract manufacturing and supply of pharmaceutical, healthcare, and nutraceutical products. This move aims to tap into high-growth sectors and diversify the current revenue stream.

Governance and Appointments

Mr. Suresh Somnath Dave has been re-appointed as an Independent Director for a second five-year term starting January 27, 2027. Additionally, the board approved a monthly remuneration of Rs 1,00,000 for non-executive directors Mr. Anant Jitendra Patel and Mrs. Krishna Utkarsh Patel.

Risks to watch

Management has flagged intense competition from lower-priced imports and domestic players as a primary risk. Additionally, the company faces exposure to raw material price volatility and potential supply chain disruptions, which could impact the margins of its core trading business.

What to track next

Investors should watch for the revenue contribution from the newly added sports and pharmaceutical business segments in the upcoming quarterly results to assess if these segments can successfully offset the volatility in the traditional chemicals trading division.